ATE221773T1 - Formulierungen mit gesteuerter freisetzung - Google Patents

Formulierungen mit gesteuerter freisetzung

Info

Publication number
ATE221773T1
ATE221773T1 AT98950189T AT98950189T ATE221773T1 AT E221773 T1 ATE221773 T1 AT E221773T1 AT 98950189 T AT98950189 T AT 98950189T AT 98950189 T AT98950189 T AT 98950189T AT E221773 T1 ATE221773 T1 AT E221773T1
Authority
AT
Austria
Prior art keywords
film
composition
forming
controlled release
water
Prior art date
Application number
AT98950189T
Other languages
English (en)
Inventor
John Michael Newton
Lee Fung Siew
Original Assignee
Btg Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Btg Int Ltd filed Critical Btg Int Ltd
Application granted granted Critical
Publication of ATE221773T1 publication Critical patent/ATE221773T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
AT98950189T 1997-10-23 1998-10-23 Formulierungen mit gesteuerter freisetzung ATE221773T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9722426.5A GB9722426D0 (en) 1997-10-23 1997-10-23 Controlled release formulations
PCT/GB1998/003178 WO1999021536A1 (en) 1997-10-23 1998-10-23 Controlled release formulations

Publications (1)

Publication Number Publication Date
ATE221773T1 true ATE221773T1 (de) 2002-08-15

Family

ID=10820995

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98950189T ATE221773T1 (de) 1997-10-23 1998-10-23 Formulierungen mit gesteuerter freisetzung

Country Status (10)

Country Link
US (1) US6534549B1 (de)
EP (1) EP1024795B1 (de)
JP (2) JP2001520986A (de)
AT (1) ATE221773T1 (de)
CA (1) CA2302585C (de)
DE (1) DE69807104T2 (de)
DK (1) DK1024795T3 (de)
ES (1) ES2178268T3 (de)
GB (1) GB9722426D0 (de)
WO (1) WO1999021536A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6929884B2 (en) * 2001-04-19 2005-08-16 Zinc Matrix Power, Inc. Method for manufacture of films containing insoluble solids embedded in cellulose-based films
US8282955B2 (en) 2001-10-15 2012-10-09 Ferring B.V. Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and Crohn's disease
GB0203421D0 (en) * 2002-02-13 2002-04-03 Alizyme Therapeutics Ltd Composition
WO2004093883A2 (en) 2003-04-23 2004-11-04 Ferring B.V. Sachet for a pharmaceutical composition
FR2862654B1 (fr) 2003-11-20 2006-02-10 Roquette Freres Composition amylacee filmogene
EP1547601A1 (de) 2003-12-23 2005-06-29 Ferring B.V. Beschichtungsverfahren
WO2005097061A1 (en) * 2004-04-01 2005-10-20 Procyte Corporation Encapsulated peptide copper complexes and compositions and methods related thereto
US8048919B2 (en) * 2004-06-28 2011-11-01 Archer Daniels Midland Company Use of ethyl lactate as an excipient for pharmaceutical compositions
US7384916B2 (en) * 2005-03-16 2008-06-10 Procyte Corporation Methods and compositions for preventing and treating aging or photodamaged skin
US20090017110A1 (en) * 2005-05-31 2009-01-15 Capricorn Pharma Inc. Modified release formulations of anti-irritability drugs
GB0607534D0 (en) 2006-04-13 2006-05-24 Univ London Pharmacy Colonic drug delivery formulation
WO2008012573A1 (en) * 2006-07-27 2008-01-31 University Of Sunderland Coating composition comprising starch
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
JP5591220B2 (ja) 2008-03-27 2014-09-17 ゼットパワー リミテッド・ライアビリティ・カンパニー 電極セパレーター
GB0808537D0 (en) 2008-05-12 2008-06-18 Archimedes Dev Ltd Compositions
FR2934467B1 (fr) * 2008-07-31 2014-08-22 Roquette Freres Forme solide pelliculee et procede de pelliculage a temperature ambiante.
EP2179727B1 (de) * 2008-10-27 2013-05-29 Roquette Freres Folienbeschichtungen aus wasserunlöslichem Polymer und modifiziertem Stärkederivat zur Dickdarmansteuerung
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
ES2628233T3 (es) 2009-01-12 2017-08-02 Biokier Inc. Composición y método para el tratamiento de la diabetes
US9314444B2 (en) 2009-01-12 2016-04-19 Biokier, Inc. Composition and method for treatment of NASH
US9006288B2 (en) 2009-01-12 2015-04-14 Biokier, Inc. Composition and method for treatment of diabetes
CN102711800A (zh) 2009-09-23 2012-10-03 拜奥基尔公司 治疗糖尿病的组合物和方法
CN102665722A (zh) 2009-10-01 2012-09-12 阿普塔利斯医药科技公司 口服给予的皮质类固醇组合物
US9963368B2 (en) 2010-11-15 2018-05-08 Archer Daniels Midland Company Microemulsions and uses thereof in dispersing catalysts
NO2659881T3 (de) 2012-04-30 2018-04-28
US20140271931A1 (en) * 2013-03-12 2014-09-18 Perosphere Inc. Anti-Acne Topical Films
KR102174942B1 (ko) 2013-10-29 2020-11-06 틸로츠 파마 아게 지연 방출 약물 제형
EP3662902A1 (de) 2018-12-07 2020-06-10 Tillotts Pharma AG Formulierung mit freisetzung eines wirkstoffs im kolon
EP3662901A1 (de) 2018-12-07 2020-06-10 Tillotts Pharma AG Arzeimittelformulierung mit verzögerter freisetzung mit einer aussenschicht enthaltend ein enzymatisch abbaubares polymer, ihre zusammensetzung und ihr herstellungsverfahren
EP3662900A1 (de) 2018-12-07 2020-06-10 Tillotts Pharma AG Kolonwirkstoffverabreichungsformulierung
EP3662898A1 (de) 2018-12-07 2020-06-10 Tillotts Pharma AG Feste formulierung enthaltend mesalazin
US11896719B2 (en) 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8926639D0 (en) * 1989-11-24 1990-01-17 Agricultural & Food Res Delayed release formulations

Also Published As

Publication number Publication date
CA2302585A1 (en) 1999-05-06
EP1024795B1 (de) 2002-08-07
CA2302585C (en) 2007-09-25
DE69807104T2 (de) 2002-12-05
EP1024795A1 (de) 2000-08-09
WO1999021536A1 (en) 1999-05-06
GB9722426D0 (en) 1997-12-24
ES2178268T3 (es) 2002-12-16
DK1024795T3 (da) 2002-12-02
DE69807104D1 (de) 2002-09-12
JP2001520986A (ja) 2001-11-06
US6534549B1 (en) 2003-03-18
JP2010270335A (ja) 2010-12-02

Similar Documents

Publication Publication Date Title
DE69807104T2 (de) Formulierungen mit gesteuerter freisetzung
DE69832621D1 (de) Pharmazeutische formulierungen mit kontrollierter freigabe von wirkstoffen
DK0729357T3 (da) Mikroindkapslede 1,2-benzazoler
DE69407404T2 (de) Feste zubereitung mit hoher freisetzung, ihre herstellung und verwendung
KR930003906A (ko) 약학적 구상 제형
DE69331906T2 (de) Granulierte pharmazeutische zusammensetzung
PT1017367E (pt) Metodos para fabricar preparacoes de libertacao controlada baseadas em polimeros
NO870558D0 (no) Fremgangsmaate for fremstilling av et langsomt frigivende farmasoeytisk preparat.
ATE356614T1 (de) Veränderung der wirkstoffladung in multivesikulären liposomen
DE69721481D1 (de) Wirkstoffformulierungen mit verzögerter freisetzung
NO964410D0 (no) Matriks-pelleter med langsom frigiving, samt fremstilling av disse
KR900002769A (ko) 장시간 작용하는 나트륨 디클로페낙의 제제
ATE273002T1 (de) Feste lösung eines fungizids mit erhöhter bioverfügbarkeit
EP0297866A3 (de) Arzneimittel
JPS5312978A (en) Isolation of low-molecular weight polymers
CA2020590A1 (en) Solid pharmaceutical composition containing a core and an outer layer
BG60697B2 (en) Medicamentous form having continous release based on ethodolacquer
CA2258679A1 (en) Solid solution of an antifungal agent with enhanced bioavailability

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner